| Item Type | Name |
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Academic Article
|
Cisplatin-based treatment of adrenocortical carcinoma.
|
|
Academic Article
|
Evaluation and treatment of testicular cancer.
|
|
Academic Article
|
Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.
|
|
Academic Article
|
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.
|
|
Academic Article
|
Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.
|
|
Academic Article
|
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
|
|
Academic Article
|
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial.
|
|
Academic Article
|
Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity.
|
|
Academic Article
|
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.
|
|
Academic Article
|
Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.
|
|
Academic Article
|
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer.
|
|
Academic Article
|
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
|
|
Academic Article
|
Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study.
|
|
Academic Article
|
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
|
|
Academic Article
|
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
|
|
Academic Article
|
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.
|
|
Academic Article
|
Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients.
|
|
Academic Article
|
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group.
|
|
Academic Article
|
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
|
|
Academic Article
|
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
|
|
Academic Article
|
Oral ondansetron: a useful addition to the supportive care armamentarium?
|
|
Academic Article
|
Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C.
|
|
Academic Article
|
Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting.
|
|
Academic Article
|
Role of adjuvant therapy in colorectal cancer.
|
|
Academic Article
|
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
|
|
Academic Article
|
Antiemetics: American Society of Clinical Oncology Focused Guideline Update.
|
|
Academic Article
|
Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.
|
|
Academic Article
|
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.
|
|
Academic Article
|
Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.
|
|
Academic Article
|
Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
|
|
Academic Article
|
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
|
|
Academic Article
|
Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon.
|
|
Academic Article
|
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
|
|
Academic Article
|
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.
|
|
Academic Article
|
Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC).
|
|
Academic Article
|
Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.
|
|
Academic Article
|
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.
|
|
Academic Article
|
Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?
|
|
Academic Article
|
Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C.
|
|
Academic Article
|
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
|